Revisiting prognostic biomarkers in gastrointestinal stromal tumor: the potential role of ETV1 polymorphisms

Journal of Gastrointestinal Oncology · Published 2026-06-01 · DOI 10.21037/jgo-2026-0273

Free full text

Authors (2)

Roberto Carmagnani Pestana, Douglas Dias e Silva

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Pestana, R., Silva, D. (2026). Revisiting prognostic biomarkers in gastrointestinal stromal tumor: the potential role of ETV1 polymorphisms. Journal of Gastrointestinal Oncology. https://doi.org/10.21037/jgo-2026-0273

Related articles

• Th1–2 immune balance revisited: refining prognostic immune signatures in colorectal cancer · Journal of Gastrointestinal Oncology · 2026 · Same journal
• From prediction to judgment: what a five-variable nomogram teaches us about hepatocellular carcinoma · Journal of Gastrointestinal Oncology · 2026 · Same journal
• Machine learning-based gastric cancer risk prediction in an asymptomatic screening population: a retrospective cohort study · Journal of Gastrointestinal Oncology · 2026 · Same journal
• Prognostic and therapeutic significance of microscopic tumor focus in combined hepatocellular-cholangiocarcinoma: a multicenter pathological study · Journal of Gastrointestinal Oncology · 2026 · Same journal
• Efficacy and safety of modified FLOT chemotherapy in gastric or gastroesophageal junction adenocarcinoma: a retrospective cohort study · Journal of Gastrointestinal Oncology · 2026 · Same journal
• Is the time of ethanol injection over?—has endoscopic ultrasonography-guided radiofrequency ablation become the preferred approach for small pancreatic neuroendocrine tumors? · Journal of Gastrointestinal Oncology · 2026 · Same journal
• A hub for an herb: is STAT3 blockade at the epicenter of toosendanin-induced NCOA4-dependent ferritinophagy and ferroptosis in cancer cells? · Journal of Gastrointestinal Oncology · 2026 · Same journal
• Real-world feasibility and safety of neoadjuvant FOLFIRINOX in pancreatic ductal adenocarcinoma: a retrospective single-center study · Journal of Gastrointestinal Oncology · 2026 · Same journal
• Association between surgical timing and postoperative outcome in patients with residual esophageal cancer after neoadjuvant chemoradiotherapy · Journal of Gastrointestinal Oncology · 2026 · Same journal
• Natural product-based nanoengineering in gastrointestinal stromal tumors: early promise and translational challenges · Journal of Gastrointestinal Oncology · 2026 · Same journal